Back
NM_000264.5:c.3647A>G
ACMG/AMP
0%
complete
Final classification
VUS
c.3647A>G
unknown
This variant

VUS: the submitted change does not match the reference sequence (c.3647 is G, not A), so no ACMG/AMP 2015 criterion could be applied and no evidence threshold was reached.

Transcript
HGVS · transcript:coding
NM_000264.5:c.3647A>G
GRCh38
GRCh37
VUS under ACMG/AMP 2015 combination rules: with no criterion met or applied, neither a pathogenic nor a benign classification threshold was reached.
Classification rationale
VUS
c.3647A>G unknown

VUS: the submitted change does not match the reference sequence (c.3647 is G, not A), so no ACMG/AMP 2015 criterion could be applied and no evidence threshold was reached.

LYFE Sciences is an AI system, and it can make mistakes. Criteria may be applied incorrectly, sources may be misread, and a confident-looking classification can still be wrong. Double-check every criterion and its underlying evidence before relying on any call.
Applied criteria · 0 applied · 28 assessed
MetEvidence satisfies this criterion.
Not metEvaluated against available evidence; threshold not reached.
Not assessedApplies in principle, but no evidence was found to evaluate it.
N/ADoesn't apply to this variant type.
Applied · 0

No criteria were applied for this variant.

Assessed · not applied · 0 not met · 28 not assessed
Pathogenic
PVS1 Not assessed: the reference base at c.3647 is G, not the submitted A, so the gene, consequence, and NMD prediction remain unresolved.
PS1 Not assessed: no previously established pathogenic variant at the same residue could be identified, since the variant's position is unconfirmed (reference base at c.3647 is G, not A).
PS2 Not assessed: no proband de novo observation or documented parental-testing result was available.
PS3 Not assessed: no validated functional assay evidence was available for this variant.
PS4 Not assessed: no case-control enrichment data were available because the variant's gene and genomic position could not be resolved.
PM1 Not assessed: the variant's residue is unconfirmed (reference base at c.3647 is G, not A), so hotspot or domain membership could not be evaluated.
PM2 Not assessed: no population database evidence established that the variant is absent or rare in the general population.
PM3 Not assessed: no proband, phase, or trans/cis observations were available to support a recessive mechanism.
PM4 Not assessed: no protein consequence or length change could be established while the c.3647 reference mismatch (G, not A) is unresolved.
PM5 Not assessed: no different missense change at the same residue established as pathogenic was available, and the residue itself is unconfirmed.
PM6 Not assessed: no case report of an apparently de novo variant without confirmed parental testing was available.
PP1 Not assessed: no family segregation observations (affected relatives or informative meioses) were available.
PP2 Not assessed: the gene is unresolved (reference base at c.3647 is G, not A), so its benign missense rate could not be evaluated.
PP3 Not assessed: no consequence or computational prediction could be evaluated because the submitted change does not match the reference (c.3647 is G, not A).
PP4 Not assessed: no gene or patient phenotype context was available, so phenotype specificity could not be judged.
PP5 Not assessed: no ClinVar expert-panel Pathogenic or Likely pathogenic record for this exact variant was available.
Benign
BA1 Not assessed: the variant could not be confirmed (c.3647 reference is G, not A), and no population-frequency data were available.
BS1 Not assessed: no population-frequency, prevalence, or penetrance data were available, and the variant's identity was unconfirmed.
BS2 Not assessed: no unaffected homozygote or hemizygote observations with phenotype and inheritance data were available.
BS3 Not assessed: no functional assay evidence demonstrating a well-established benign effect was available.
BS4 Not assessed: no unaffected informative relatives with genotype and phenotype data were available.
BP1 Not assessed: the gene and even the missense class are unconfirmed, and a truncating-only disease mechanism was not established.
BP2 Not assessed: no cis/trans observation with another pathogenic variant or family segregation data was available.
BP3 Not assessed: no evidence of an in-frame protein length change or a functionally silent repetitive-region location was available.
BP4 Not assessed: no validated consequence or calibrated benign computational prediction was available for this unconfirmed variant.
BP5 Not assessed: no affected individual, phenotype, or independent molecular diagnosis was available for this variant.
BP6 Not assessed: no ClinVar expert-panel Benign or Likely benign record for this exact variant was available.
BP7 Not assessed: synonymous status could not be established because the submitted change mismatches the reference at c.3647 (G, not A).
Research & evidence
Population frequency
v4.1
This variant is absent from gnomAD v4.1.
v2.1
This variant is absent from gnomAD v2.1.
🇨🇦 CA
This variant is absent from gnomAD-Canada.
Allele frequency by ancestry
three datasets · side by side
gnomAD Canada 🇨🇦
Absent · 0 / ?
0 hom
Not observed in any ancestry group.
ClinVar No data
No ClinVar submissions were recorded for this variant.
In silico No data
No in-silico prediction was recorded for this variant.
Functional No data
No calibrated functional assay or RNA evidence was identified for this variant.
Somatic evidence
COSMIC
This variant has not previously been reported in somatic cancers (COSMIC).
Hotspots
This variant does not lie in a statistically significant cancer hotspot.
Sources & reference links

No sources recorded.